Uwe Eiermann

Title: Uwe Eiermann: Innovator in Pharmaceutical Polymorphs

Introduction

Uwe Eiermann is a notable inventor based in Ladenburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymorphs for various compounds. With a total of 2 patents, Eiermann's work has implications for drug formulation and efficacy.

Latest Patents

Eiermann's latest patents focus on Ibandronate polymorphs. The first patent describes a new polymorph crystal form of 3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-diphosphonic acid monosodium salt monohydrate (Ibandronate) with a specific formula. The second patent also relates to a new crystalline polymorph of the same compound, emphasizing the importance of polymorphic forms in pharmaceutical applications.

Career Highlights

Throughout his career, Uwe Eiermann has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in drug development and formulation.

Collaborations

Eiermann has collaborated with several professionals in his field, including Bernhard Knipp and Tim Sattelkau. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical sciences.

Conclusion

Uwe Eiermann's contributions to the field of pharmaceuticals, particularly through his patents on Ibandronate polymorphs, highlight his role as an innovator. His work continues to influence drug formulation and efficacy in the pharmaceutical industry.